Document Details
Form
Filing Date
Mar 4, 2024
Document Date
Feb 29, 2024
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioCryst Pharmaceuticals, Inc.
Issuer
BIOCRYST PHARMACEUTICALS INC
Filer
MILANO VINCENT